WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry

    SHANGHAI, China, Aug. 22 /Xinhua-EMWNews/ -- WuXi PharmaTech (NYSE:

WX), a leading pharmaceutical, biotechnology and medical device research

and development outsourcing company with operations in China and the United

States, today announced that it has promoted Dr. Rujian Ma to Vice

President of Synthetic Chemistry.



    



    Dr. Ma will report directly to Dr. Shuhui Chen, Chief Scientific

Officer of WuXi PharmaTech.



    "I am very delighted to promote Dr. Ma to this new leadership position.

Dr. Ma's depth of synthetic chemistry experience and his commitment and

coaching capabilities of our young scientists undoubtedly will further

accelerate the development of our core synthetic chemistry division. His

new assignment will also help us continually improve our service quality

and productivity and to serve our customers better." commented Dr. Shuhui

Chen, Chief Scientific Officer of WuXi PharmaTech.



    Dr. Ma received his Ph.D. in Organic Chemistry from the University of

Tokushima, Japan and joined in WuXi in March 2001.

    About WuXi PharmaTech



    WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical

device R&D outsourcing company, with operations in China and the United

States. As a research-driven and customer-focused company, WuXi PharmaTech

provides pharmaceutical, biotechnology and medical device companies a broad

and integrated portfolio of laboratory and manufacturing services

throughout the drug and medical device R&D process. WuXi PharmaTech's

services are designed to assist its global partners in shortening the cycle

and lowering the cost of drug and medical device R&D. For more information,

please visit: http://www.wuxipharmatech.com .



    For more information, please contact:



    Sherry Shao



    Tel: +86-21-5046-4002



    Email: [email protected]